What are MIGS (minimally invasive glaucoma surgeries)? 

Minimally Invasive Glaucoma Surgeries, commonly referred to as MIGS, represent a modern group of surgical procedures designed to lower intraocular pressure with a higher safety profile than traditional glaucoma operations. These techniques typically involve the use of microscopic equipment and tiny incisions, often performed through the same small opening used during cataract surgery. By focusing on reducing the dependency on daily eye drops and providing a faster recovery period, MIGS has become a popular option for patients with mild to moderate glaucoma. Unlike older, more invasive surgeries like trabeculectomy, MIGS aims to enhance the eye’s natural drainage pathways with minimal trauma to the surrounding ocular tissues. 

What We’ll Discuss in This Article 

• The defining characteristics and primary goals of MIGS procedures. 

• Different types of MIGS, including micro-stents and internal bypasses. 

• The benefits of combining MIGS with routine cataract surgery. 

• Patient eligibility and the ideal candidates for these interventions. 

• How MIGS compares to traditional glaucoma surgeries in terms of risk. 

• Expected outcomes regarding eye pressure reduction and medication use. 

• Post-operative recovery and long term follow up expectations. 

The Evolution of Minimally Invasive Glaucoma Surgery 

The development of MIGS was driven by the need for a “middle ground” in glaucoma treatment. For many years, patients were limited to either using lifelong eye drops or undergoing major surgery, which often carried significant risks of complications. MIGS provides an intermediate step, offering a surgical solution that is safer than traditional operations while being more effective than medications for some individuals. These procedures are categorized by their minimal impact on the sclera and conjunctiva, preserving these tissues for potential future surgeries if needed. 

Most MIGS procedures work by bypassing the resistance in the trabecular meshwork, the eye’s primary drainage site. By creating a clear channel or inserting a microscopic stent, the fluid (aqueous humor) can flow more easily out of the eye. Because the techniques are so refined, they often take only a few minutes to complete and can be performed under local anaesthetic. This approach has significantly expanded the surgical options available to UK patients, as outlined in the clinical updates provided by NICE on glaucoma procedures. 

Types of MIGS Procedures 

There are several different types of MIGS, each targeting a specific area of the eye’s drainage system. The choice of procedure often depends on the patient’s specific eye anatomy and the degree of pressure reduction required. Some focus on the trabecular meshwork, while others target the space between the iris and the sclera (the suprachoroidal space) or the subconjunctival space. 

One common example is the iStent, a microscopic titanium device that is placed into the drainage canal to bypass blockages. Another is the Hydrus Microstent, which dilates the drainage canal to improve flow. Some procedures, like the Xen Gel Stent, create a brand-new drainage pathway using a tiny, flexible tube. While they all vary in design, the shared objective is to achieve a consistent lowering of intraocular pressure with the lowest possible risk of infection or severe vision changes. 

Comparison of MIGS and Traditional Surgery 

MIGS is often compared to traditional filtration surgeries like trabeculectomy or aqueous shunt implantation. While traditional surgeries are usually more effective at achieving very low eye pressures in advanced cases, they carry a higher risk of complications such as hypotony (very low eye pressure), infection, or long-term scarring. MIGS, on the other hand, prioritizes safety and a rapid return to normal activities. 

Feature	MIGS Procedures	Traditional Surgery (Trabeculectomy)
Primary Goal	Moderate pressure reduction	Significant pressure reduction
Risk Profile	Very low risk of serious complications	Moderate risk of complications
Recovery Time	Very fast (days)	Moderate (weeks to months)
Tissue Impact	Minimal (micro-incisions)	Significant (tissue flaps/stitching)
Medication Need	Often reduced	Frequently eliminated

Because MIGS is less invasive, it is generally recommended for patients whose glaucoma is in the early to moderate stages. For those with very advanced disease or extremely high pressure, traditional surgery remains the more appropriate “gold standard” to prevent total vision loss. The decision is always based on a careful assessment of the patient’s individual risk factors and the severity of their optic nerve damage. 

Patient Eligibility and Ideal Candidates 

Not every glaucoma patient is a candidate for MIGS. The best candidates are typically those with mild to moderate open-angle glaucoma who are already using one or more eye drops to control their pressure. MIGS is also an excellent option for patients who find eye drops difficult to use due to allergies, side effects, or physical limitations. Because the procedures are so safe, they can be considered much earlier in the treatment journey than traditional surgery. 

Clinicians also evaluate the “drainage angle” of the eye before recommending MIGS. These procedures are primarily designed for “open-angle” cases, where the drainage site is visible but blocked. If a patient has narrow angles or other complex eye conditions, a different type of laser or surgical intervention might be more effective. A thorough consultation with a glaucoma specialist is necessary to determine which specific MIGS device or technique is most suitable. 

Expected Outcomes and Recovery 

Recovery from MIGS is typically very quick. Most patients experience clear vision within a few days, and there is usually very little discomfort. While some patients may be able to stop using their glaucoma eye drops entirely after the procedure, others may still require a reduced dose to maintain their target pressure. The success of the surgery is monitored through regular pressure checks in the weeks and months following the operation. 

Long term studies indicate that MIGS procedures are effective at maintaining stable pressure for several years. However, like all glaucoma treatments, the effect can occasionally diminish over time. One of the key benefits of MIGS is that it does not “burn any bridges,” meaning that if the pressure rises again in the future, the patient can still safely undergo traditional surgery or additional laser treatments. This flexibility makes MIGS a valuable tool in the lifelong management of the condition. 

Conclusion 

MIGS represents a significant advancement in the management of glaucoma, offering a safer and less invasive alternative to traditional surgery for patients with mild to moderate disease. By using microscopic stents and refined techniques, these procedures can effectively lower eye pressure and reduce the daily burden of eye drops with minimal recovery time. While they may not be suitable for every stage of the condition, MIGS provides an essential option for preserving vision and improving patient wellbeing. If you experience severe, sudden, or worsening symptoms, such as sudden vision loss or intense eye pain, call 999 immediately. 

Authority Snapshot 

This article provides an overview of Minimally Invasive Glaucoma Surgeries (MIGS) and their role in modern glaucoma management. The content has been developed and reviewed by the medical content team to ensure high clinical standards and patient safety. All information provided is strictly aligned with NHS and NICE protocols, reflecting current UK clinical practice for the safe and effective reduction of intraocular pressure.